JPWO2021014166A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021014166A5
JPWO2021014166A5 JP2022504089A JP2022504089A JPWO2021014166A5 JP WO2021014166 A5 JPWO2021014166 A5 JP WO2021014166A5 JP 2022504089 A JP2022504089 A JP 2022504089A JP 2022504089 A JP2022504089 A JP 2022504089A JP WO2021014166 A5 JPWO2021014166 A5 JP WO2021014166A5
Authority
JP
Japan
Prior art keywords
hydroxy
compound
carboxamide
acetyl
pyridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022504089A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022541311A (ja
JP7583022B2 (ja
Publication date
Priority claimed from GBGB1910607.9A external-priority patent/GB201910607D0/en
Priority claimed from GBGB2005739.4A external-priority patent/GB202005739D0/en
Application filed filed Critical
Priority claimed from PCT/GB2020/051778 external-priority patent/WO2021014166A1/en
Publication of JP2022541311A publication Critical patent/JP2022541311A/ja
Publication of JPWO2021014166A5 publication Critical patent/JPWO2021014166A5/ja
Application granted granted Critical
Publication of JP7583022B2 publication Critical patent/JP7583022B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022504089A 2019-07-24 2020-07-24 呼吸器症状の治療における使用のためのtmem16aモジュレータとしてのピリジン誘導体 Active JP7583022B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB1910607.9A GB201910607D0 (en) 2019-07-24 2019-07-24 Compounds
GB1910607.9 2019-07-24
GB2005739.4 2020-04-20
GBGB2005739.4A GB202005739D0 (en) 2020-04-20 2020-04-20 Compounds
PCT/GB2020/051778 WO2021014166A1 (en) 2019-07-24 2020-07-24 Pyridine derivatives as tmem16a modulators for use in the treatment of respiratory conditions

Publications (3)

Publication Number Publication Date
JP2022541311A JP2022541311A (ja) 2022-09-22
JPWO2021014166A5 true JPWO2021014166A5 (enExample) 2023-07-25
JP7583022B2 JP7583022B2 (ja) 2024-11-13

Family

ID=71948615

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022504089A Active JP7583022B2 (ja) 2019-07-24 2020-07-24 呼吸器症状の治療における使用のためのtmem16aモジュレータとしてのピリジン誘導体

Country Status (16)

Country Link
US (1) US20220235006A1 (enExample)
EP (1) EP4003516A1 (enExample)
JP (1) JP7583022B2 (enExample)
KR (1) KR20220063162A (enExample)
CN (1) CN114616226B (enExample)
AU (1) AU2020317036A1 (enExample)
BR (1) BR112022001164A2 (enExample)
CA (1) CA3145120A1 (enExample)
CL (1) CL2022000147A1 (enExample)
CO (1) CO2022002022A2 (enExample)
CR (1) CR20220072A (enExample)
IL (1) IL290035A (enExample)
MX (1) MX2022000841A (enExample)
PE (1) PE20221441A1 (enExample)
PH (1) PH12022550181A1 (enExample)
WO (1) WO2021014166A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20221441A1 (es) * 2019-07-24 2022-09-21 Tmem16A Ltd Derivados de piridina como moduladores de tmem16a para su uso en el tratamiento de afecciones respiratorias
KR20260025059A (ko) * 2024-08-13 2026-02-23 전남대학교산학협력단 신규한 치환된 피리딘 유도체 화합물, 이의 제조방법, 및 이를 유효성분으로 포함하는 호흡기 질환의 예방 또는 치료용 약학적 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050176767A1 (en) * 2003-10-30 2005-08-11 Laval Chan Chun Kong Pyridine carboxamide and methods for inhibiting HIV integrase
EP3612180B1 (en) * 2017-04-17 2023-10-11 The Regents of the University of California Substituted 2-acylamino-cycloalkylthiophene-3-carboxylic acid arylamides as inhibitors of calcium-activated chloride channel tmem16a
GB201801355D0 (en) * 2018-01-26 2018-03-14 Enterprise Therapeutics Ltd Compounds
PE20221441A1 (es) * 2019-07-24 2022-09-21 Tmem16A Ltd Derivados de piridina como moduladores de tmem16a para su uso en el tratamiento de afecciones respiratorias

Similar Documents

Publication Publication Date Title
JP2024050527A5 (enExample)
JP2006501295A5 (enExample)
AU2016202676B2 (en) Polycyclic antagonists of lysophosphatidic acid receptors
RU2419624C2 (ru) Сульфонамидные производные как активаторы гликокиназы, применимые для лечения диабета типа 2
RU2361860C2 (ru) Новые замещенные 3-сера-индолы
JP2004502670A5 (enExample)
JP2019038820A5 (enExample)
RU2009102278A (ru) Модуляторы рецептора s1p для лечения рассеянного склероза
JP2014530900A5 (enExample)
JP2007502806A5 (enExample)
RU2004117887A (ru) Ариланилиновые агонисты бета2 адренергических рецепторов
RU2004104625A (ru) Аналоги простагландинов в качестве агонистов рецептора ep4
RU2007101236A (ru) Новые гидантоиновые производные для лечения обструктивных заболеваний дыхательных путей
RU2012125372A (ru) Производные пиразола в качестве ингибиторов 11-бета-hsd1
JP2013531070A5 (enExample)
JP2011506469A5 (enExample)
RU2013130879A (ru) Производные оксазолилметилового эфира в качестве агонистов рецептора alx
JP2004524345A5 (enExample)
JPWO2019145726A5 (enExample)
US20220324811A1 (en) 1,3-substituted cyclobutyl derivatives and uses thereof
JPWO2020084492A5 (enExample)
JPWO2021014166A5 (enExample)
RU2018127494A (ru) Химические соединения в качестве ингибиторов киназной активности
JPWO2020084480A5 (enExample)
RU2015114405A (ru) Замещенные соединения фенилкарбамата